Dhampur Bio Organics Limited has informed the Exchange about Investor Presentation
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics reported FY25 revenue of ₹2,714.40 Crores, up 14.96% YoY, driven by 9.94% growth in Sugar and 55.63% growth in Country Liquor segments. However, overall profitability took a sharp hit, with FY25 EBITDA down 11.11% YoY to ₹143.64 Crores and PAT plunging 75.24% YoY to just ₹12.09 Crores (margin 0.45%). The Bio-Fuel & Spirits segment was the main drag, with revenue declining 34.29% and EBIT margin collapsing from 10.83% to 3.20% in FY25. In Q4FY25, performance was relatively better with revenue up 18.14% to ₹702.48 Crores, EBITDA up 14.33% to ₹99.54 Crores, and Sugar segment EBIT margin improving to 18.78% from 15.46%. The company remains low-leveraged with long-term debt-to-equity at 0.30x and repaid ₹64.26 Crores of long-term loans during FY25.
Mixed signals for shareholders: strong revenue growth and improving Sugar segment margins are positives, but the severe Bio-Fuel margin compression and 75% PAT decline in FY25 highlight significant earnings weakness. Stock may face pressure due to the weak FY25 bottom line, though low debt and Q4 recovery in Sugar provide some support.